TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer's disease and frontotemporal lobar degeneration.

TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer's disease and frontotemporal lobar degeneration.
复制标题

DOI:
10.1007/s00401-008-0389-8
复制
发表时间:
2008-08
影响因子:
12.7
通讯作者:
Mann DM
Mann DM
中科院分区:
医学1区
文献类型:
--
作者:
Foulds P;McAuley E;Gibbons L;Davidson Y;Pickering-Brown SM;Neary D;Snowden JS;Allsop D;Mann DM

文献摘要

参考文献

被引文献

相似文献

尸检研究表明,约55%的额颞叶变性(FTLD)患者和25%的阿尔茨海默病(AD)患者的大脑中存在TDP-43免疫反应性病理变化。使用ELISA,我们研究了与正常对照受试者相比,我们是否可以检测到FTLD和AD患者血浆中TDP-43的存在或增加的量。我们检测到升高的TDP-43蛋白在血浆中的FTLD与临床额颞叶痴呆(FTD)患者的46%和AD患者的22%,相比对照组的8%。血浆TDP-43水平升高的FTD和AD患者比例与尸检研究中已知脑内存在TDP-43病理变化的患者比例密切对应。因此,升高的TDP-43血浆水平可以指示脑内的TDP-43病理。血浆TDP-43水平可以是生物标志物,其可以提供能够鉴定生命期间神经退行性疾病中TDP-43脑病理学的存在的实验室测试。这可能有助于区分那些FTLD的情况下,泛素/TDP-43病理在他们的大脑与tau蛋白病变。血浆TDP-43水平作为一种预测性试验,在指导旨在预防或消除FTLD和AD脑中tau或TDP-43病理变化的治疗策略方面可能具有很大的实用价值。
Autopsy studies have shown that about 55% of patients with frontotemporal lobar degeneration (FTLD) and 25% of patients with Alzheimer’s disease (AD) harbour TDP-43 immunoreactive pathological changes in their brains. Using ELISA, we investigated whether we could detect the presence, or increased amounts, of TDP-43 in plasma of patients with FTLD and AD compared to normal control subjects. We detected elevated levels of TDP-43 protein in plasma of 46% patients with FTLD with clinical frontotemporal dementia (FTD) and 22% patients with AD, compared to 8% of control subjects. The proportions of patients with FTD and AD showing raised plasma TDP-43 levels correspond closely to those proportions known from autopsy studies to contain TDP-43 pathological changes in their brains. Raised TDP-43 plasma levels may thereby index TDP-43 pathology within the brain. Plasma TDP-43 levels may be a biomarker that can provide a laboratory test capable of identifying the presence of TDP-43 brain pathology in neurodegenerative disease during life. It may help to distinguish those cases of FTLD with ubiquitin/TDP-43 pathology in their brains from those with tauopathy. As a predictive test, plasma TDP-43 level may have great practical value in directing therapeutic strategies aimed at preventing or removing tau or TDP-43 pathological changes from the brain in FTLD and AD.
DOI: 10.1038/nature05017
发表时间: 2006-08-24
期刊: NATURE
影响因子: 64.8
作者:
Cruts, Marc;Gijselinck, Ilse;Van Broeckhoven, Christine
通讯作者: Van Broeckhoven, Christine
DOI: 10.1093/brain/awl289
发表时间: 2006-11-01
期刊: BRAIN
影响因子: 14.5
作者:
Pickering-Brown, Stuart M.;Baker, Matt;Hutton, Mike
通讯作者: Hutton, Mike
DOI: 10.1034/j.1600-0404.2002.01225.x
发表时间: 2002-09-01
影响因子: 3.5
作者:
Hänninen, T;Hallikainen, M;Soininen, H
通讯作者: Soininen, H
DOI: 10.2353/ajpath.2007.070182
发表时间: 2007-07-01
影响因子: 6
作者:
Cairns, Nigel J.;Neumann, Manuela;Mackenzie, Ian R. A.
通讯作者: Mackenzie, Ian R. A.
DOI: 10.1038/nature05016
发表时间: 2006-08-24
期刊: NATURE
影响因子: 64.8
作者:
Baker, Matt;Mackenzie, Ian R.;Hutton, Mike
通讯作者: Hutton, Mike